M-TRAM program is the first Stanford graduate program that specifically focuses on translation of medical research into actionable changes in therapeutics and diagnostics of human disease and is the first program of this kind on the West Coast. Our program fills is competitive to similar programs at other leading universities that already have translational research programs. Both Harvard and UPenn admit external and internal candidates, however eligibility is restricted to professionals holding and MD or PhD degrees. However, M-TRAM admits not only graduate degree-holding professionals, but also recent college graduates and co-term medical students. Our program is also unique in offering a one-year curriculum, as opposed to others’ two-year programs, making it more attractive to individuals who are unable to enroll in two-year programs.
Unlike many other Master’s degree programs based on didactic teaching, M-TRAM students engage in experiential learning with formal research training experience (TRIP capstone mentored research project), as well as hands-on training in translational research technology and therapeutic development, the opportunity to gain experience working with a biotechnology company and a research laboratory, and clinical experiences (for non-physicians) and research experiences (for physicians).
Stanford is an exceptional environment to train in medical translation because of our world-class expertise in medical science and bioengineering, with specific expertise in immunology, oncology, vaccines, radiology/imaging, and cardiovascular disease. Moreover, the way Stanford melds exceptional clinical and research programs in medicine, business, and technology has no peer in higher education in this country. Research across the University breaks new ground almost daily in terms of cutting-edge research technologies, innovations, and clinical applications, with health care serving as an amazing translational opportunity for these advances.